SCHEMBL19260864

SCHEMBL19260864

C[Si](C)(C)CCOCn1cc(CC#N)c2cccnc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DGAT1 O75907 1/20 0.34
▸ APP P05067 2/20 0.33
▸ SNCA P37840 2/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ CNR2 P34972 1/20 0.33
▸ EGFR P00533 1/20 0.33
▸ IGF1R P08069 1/20 0.33
▸ SRC P12931 1/20 0.33
▸ FLT4 P35916 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ FLT3 P36888 1/20 0.33
▸ EPHB4 P54760 1/20 0.33
▸ TEK Q02763 1/20 0.33
▸ ELANE P08246 5/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ GSK3B P49841 3/20 0.32
▸ CFTR P13569 1/20 0.32
▸ CCNB2 O95067 1/20 0.32
▸ PRKCB P05771 1/20 0.32
▸ CDK1 P06493 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30848403 0.84 NPC1 (0.36) DGAT1CNR1CNR2EGFRIGF1R
SCHEMBL29514362 0.83 ELANE (0.47) ELANECFTR
SCHEMBL30848448 0.82 HTR6 (0.37) DGAT1EGFRIGF1RSRCFLT4
SCHEMBL31710694 0.82 DYRK1A (0.35) DGAT1APPSNCAEGFRIGF1R
SCHEMBL19273391 0.81 EGFR (0.35) DGAT1EGFRIGF1RSRCFLT4
SCHEMBL31050029 0.80 DGAT1 (0.40) DGAT1CNR1CNR2EGFRIGF1R
SCHEMBL15533247 0.80 EGFR (0.34) DGAT1CNR1CNR2EGFRIGF1R
SCHEMBL19260892 0.80 DGAT1 (0.35) DGAT1APPSNCACNR1CNR2
SCHEMBL21044790 0.79 DGAT1 (0.41) DGAT1CNR1CNR2EGFRIGF1R
SCHEMBL29748840 0.79 DGAT1 (0.41) DGAT1CNR1CNR2EGFRIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018213422-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS (US) 2018-11-22 — — WO disclosed
WO-2017143134-A1 FXR MODULATORS AND METHODS OF THEIR USE ALIOS BIOPHARMA, INC. (US) 2017-08-24 — — WO disclosed
WO-2017143134-A1 FXR MODULATORS AND METHODS OF THEIR USE ALIOS BIOPHARMA, INC. (US) 2017-08-24 — — WO disclosed
Send feedback